Le Lézard
Classified in: Health
Subject: SVY

Global Pharmaceutical Traceability Market 2017-2021 - Growing Concern of Drug Counterfeit and Theft


DUBLIN, October 5, 2017 /PRNewswire/ --

The "Global Pharmaceutical Traceability Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The global pharmaceutical traceability market to grow at a CAGR of 19.25% during the period 2017-2021.

Global Pharmaceutical Traceability Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is Blockchain technology. Blockchain is a distributed ledger that records and stores information. The main features that make it unique are decentralization and immutability. Another feature is the authentication or verification of the product, before adding an information or giving access to information, the technology uniquely identifies the product.

According to the report, one of the major drivers for this market is Growing concern of drug counterfeit and theft. Counterfeit drugs are medicines that are manufactured in a fraudulent manner or can be mislabeled with different ingredients, source or other information. Illegal diversion of drugs is a major issue. Illegal diversion is the sales of drugs in countries apart from the ones where the drug is legally approved to be sold. Pharmaceutical theft can occur at any point in the supply chain, like manufacturer, wholesaler or distributor. Customers buy fake medicines either due to the lack of awareness or low price of such drugs.

Further, the report states that one of the major factors hindering the growth of this market is No global standard for serialization of drugs across the world. No global standards for serialization are adopted by the nations. Developing countries have come up with their own standards and regulations for serializing the drugs. Different countries follow different standards when serial numbers are assigned to the drug lots or batches.

Key vendors



Other prominent vendors

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Segmentation By Technology

Part 06: Geographical Segmentation

Part 07: Decision Framework

Part 08: Drivers And Challenges

Part 09: Market Trends

Part 10: Vendor Landscape

For more information about this report visit https://www.researchandmarkets.com/research/5xk4cq/global


Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




These press releases may also interest you

at 08:10
bioAffinity Technologies, Inc. , a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, today announced David Elzi, Ph.D., has been named Vice President of...

at 08:10
Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced the availability of Over the Counter ("OTC") Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg, following Abbreviated New Drug Application ("ANDA") approval from the...

at 08:10
BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform announced a collaboration with Janssen Biotech Inc., a Johnson & Johnson company. This strategic...

at 08:10
Kiromic BioPharma, Inc. ("Kiromic" or the "Company") announces consistent favorable safety, tolerability, and efficacy from follow-up visits of the first cohort of three patients enrolled in the Company's Deltacel-01 Phase 1 clinical trial....

at 08:05
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on July 1, 2024, to stockholders of record on June 3, 2024. About McKesson Corporation...

at 08:05
symplr®, a leading provider of enterprise healthcare operations software, today announced a new partnership integrating award-winning healthcare worker payments technology from Branch, a workforce payments platform. With the integrated pay solution,...



News published on and distributed by: